# OnCo record heidelberg-pharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/heidelberg-pharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "heidelberg-pharma" ;
  schema:name "Heidelberg Pharma"@en ;
  schema:alternateName "Heidelberg Pharma AG"@en ;
  schema:description "Heidelberg Pharma is a German company building antibody-drug conjugates around amanitin, a toxin from the death cap mushroom that kills cells by blocking RNA polymerase II, with its lead candidate HDP-101 in multiple myeloma."@en ;
  schema:url <https://onco.cc/companies/heidelberg-pharma/>, <https://heidelberg-pharma.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://heidelberg-pharma.com>, <https://clinicaltrials.gov/search?lead=Heidelberg%20Pharma>, <https://en.wikipedia.org/wiki/Heidelberg_Pharma> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "DE" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/bcma/> ;
  onco:companies <https://onco.cc/companies/takeda/> ;
  onco:trials <https://onco.cc/trials/nct04879043/> .